We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » France Levies Massive Fines on Novartis, Roche for Anticompetitive AMD Drug Practices
France Levies Massive Fines on Novartis, Roche for Anticompetitive AMD Drug Practices
Novartis and Roche have been hit with a combined $526 million in fines by France’s competition regulator for using “abusive practices” to boost sales for an expensive age-related macular degeneration (AMD) drug by discouraging a much cheaper alternative.